EPW.CN - Empower Clinics Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.1850
+0.0150 (+8.82%)
As of 3:59PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.1700
Open0.1700
Bid0.1800 x 0
Ask0.1850 x 0
Day's Range0.1600 - 0.1850
52 Week Range0.0650 - 0.4700
Volume156,178
Avg. Volume212,141
Market Cap18.23M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • AgraFlora Organics Applauds Corporate Rebranding of Empower Clinics Inc.
    CNW Grouplast month

    AgraFlora Organics Applauds Corporate Rebranding of Empower Clinics Inc.

    VANCOUVER, April 11, 2019 /CNW/ - AgraFlora Organics International Inc.  ("AgraFlora" or the "Company") (CSE: AGRA) (Frankfurt:PU31.F - News) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, applauds the recently announced corporate rebranding of investee company Empower Clinics Inc. (CSE:EPW.CN - News) (Frankfurt 8EC) to better reflect their refocused and refreshed corporate profile and streamlined strategy to become a vertically integrated health and wellness company offering cannabidiol (CBD) based therapies, products and treatment options.  As part of the rebranding, Empower will seek shareholder approval for a name change to "CBD Therapeutics Corp." and it has changed its ticker symbol on the Canadian Securities Exchange to "CBDT". "AgraFlora committed $1 million as a lead strategic investor in the recent financing by Empower Clinics Inc. as we continue to expand our footprint through strategic partnerships and co-operation in the global cannabis sector," said Derek Ivany, President & CEO of AgraFlora Organics International Inc. "With the recent passing of the Farm Bill in the United States and the associated legalization of hemp and hemp based products, opportunities abound for the production and sale of a variety of CBD based products to the benefit of consumers' health and wellness.

  • Empower Announces Ticker Symbol Change, New Website and Pending Company Name Change
    CNW Grouplast month

    Empower Announces Ticker Symbol Change, New Website and Pending Company Name Change

    Empower Clinics Inc. has changed its ticker symbol to CSE: CBDT and proposes to change the Company name to CBD Therapeutics Corporation at the Company annual general meeting in June 2019. VANCOUVER, April 10, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company"), a growth oriented, diversified health and wellness company, announces that it has changed the Company's ticker symbol on the Canadian Securities Exchange (the "CSE") to CSE: CBDT.

  • AgraFlora Organics Makes Strategic Investment and Empower Announces Closing of Debenture and Private Placement Unit Offerings
    CNW Group2 months ago

    AgraFlora Organics Makes Strategic Investment and Empower Announces Closing of Debenture and Private Placement Unit Offerings

    VANCOUVER, April 2, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company"), a growth oriented and diversified medical cannabis company, is pleased to announce the closing of its non-brokered private placement of unsecured convertible debentures (the "Debentures") in the aggregate principal amount of $799,500.00 and its non-brokered private placement of an aggregate of 21,115,000 units of the Company (each, a Unit") at a price of $0.10 per Unit for gross proceeds of $2,115,000.00 for a total of $2,914,500.00 (together, the "Offerings"). The proceeds of the Offerings are expected to be used by the Company for the completion of strategic acquisitions and for general working capital and corporate purposes.

  • Empower Amends Terms of Debenture Offering and Announces Non-Brokered Private Placement of Units
    CNW Group2 months ago

    Empower Amends Terms of Debenture Offering and Announces Non-Brokered Private Placement of Units

    /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / VANCOUVER , March 22, 2019 /CNW/ - EMPOWER CLINICS INC.  (CSE: EPW) (Frankfurt 8EC) (" Empower ...

  • GlobeNewswire2 months ago

    Datametrex Provides Update on Canntop AI Pilot Program with Empower

    Datametrex AI Limited (DM.V) (the “Company” or “Datametrex”) is pleased to provide update on its pilot program with EMPOWER CLINICS INC. (CSE: EPW) (“Empower”) through its subsidiary Canntop AI Inc. (“Canntop”) to develop a deeper understanding of patients’ awareness of cannabis-based treatment options and the ongoing effectiveness. “We are thrilled that Empower chose Canntop to be their partner for their Artificial Intelligence needs.

  • CNW Group2 months ago

    Empower Announces Updates to AI Pilot Program

    VANCOUVER, March 19, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt: 8EC) ("Empower" or the "Company"), a growth oriented and diversified medical cannabis company, is pleased to provide an update on recent activities by the technical teams at Empower and Canntop AI Inc. ("Canntop"), a subsidiary of Datametrex AI Limited ("Datametrex") to develop a deeper understanding of patient awareness of cannabis-based treatment options and ongoing effectiveness of treatment programs.

  • Empower Clinics Provides Corporate Update and Announces New Chief Financial Officer
    CNW Group2 months ago

    Empower Clinics Provides Corporate Update and Announces New Chief Financial Officer

    VANCOUVER, March 13, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company"), a growth oriented and diversified medical cannabis company, is pleased to provide an update on recent corporate activities after announcing proposed acquisitions and partnerships intended to re-shape the profile of the Company going forward. The Company has reached a number of important milestones over the past eight weeks as it continues its path forward, striving to become a global health and wellness company, serving the needs of patients through its network of physician-staffed health and pain management clinics and CBD extraction operations. Intention to Launch CBD Extraction Facility The Company intends to open a fully functioning hemp-based CBD extraction facility in greater Portland, Oregon in Q2 2019, with the first extraction system expected to have the capacity to produce 6,000 kilograms of extracted product per year.

  • Empower Clinics Announces Private Placement of Convertible Debentures
    CNW Group3 months ago

    Empower Clinics Announces Private Placement of Convertible Debentures

    VANCOUVER, March 4, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: EPW) (Frankfurt 8EC) ("Empower" or the "Company") today announces it will be conducting a non-brokered private placement (the "Financing") of unsecured convertible debentures (each, a "Debenture") in the aggregate principal amount of up to $1,500,000. Each Debenture will be convertible into units of the Company (each, a "Unit") at a conversion price of $0.15 per Unit, with each Unit to consist of one common share in the capital of the Company (each, a "Share") and one non-transferable share purchase warrant (each, a "Warrant"). Each Warrant will entitle the holder to purchase one Share at a price of $0.20 per Share for a period of two years from the closing of the Financing (the "Closing"), subject to acceleration in the event that the closing price of the Shares on the Canadian Securities Exchange (the "CSE"), or such other stock exchange as the Shares are then principally traded, is greater than $0.40 per Share for at least 10 consecutive trading days.

  • Empower Announces Intent to Open CBD Extraction Facility
    CNW Group3 months ago

    Empower Announces Intent to Open CBD Extraction Facility

    VANCOUVER, Feb. 28, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: EPW) (Frankfurt 8EC) ("Empower" or the "Company") today announces it intends to open a fully functioning hemp-based CBD extraction facility in greater Portland, Oregon in Q2 2019 with the first extraction system expected to have the capacity to produce 6,000 kg of extracted product per year. Aibeida's director and Chief Scientist, Dr. Shuang Xie, PhD., in Canada will oversee and manage the Empower CBD extraction facility, which is expected to provide Empower with vertical integration into the CBD supply chain, producing isolates, distillates and crude oil that have shown successful third party test results in the initial test facility. "Achieving vertical integration has been an objective of mine from the outset as we attempt to connect the science behind hemp-derived CBD based therapies and the efficacy of physician recommended treatment options made available through our clinic network, online or through retail partnerships," stated Steven McAuley, CEO of Empower.

  • GlobeNewswire3 months ago

    Datametrex Announces Cannabis AI Pilot Program With Empower

    Datametrex AI Limited (DM.V) (the “Company” or “Datametrex”) is pleased to announce its agreement to partner with EMPOWER CLINICS INC. (CSE: EPW) (“Empower”) through its subsidiary Canntop AI Inc. (“Canntop”) on the creation of a pilot program (“Pilot”) using Artificial Intelligence (“AI”) to analyze and gain insights about Empower patient data, physician treatment recommendations and overall long-term efficacy of patient care. This is to identify improvements and efficacy in long-term patient care. Empower intends to use Canntop’s AI platform to gain actionable insights on how consumer social data is generating nationwide interest in CBD based products, alternative pain management options and the use of cannabis-based therapies.

  • Empower Announces AI Pilot Program
    CNW Group3 months ago

    Empower Announces AI Pilot Program

    VANCOUVER, Feb. 5, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company") today announces it intends to partner with Datametrex AI Limited ("Datametrex") and its subsidiary, Canntop AI Inc. ("Canntop"), to create a pilot program that uses Artificial Intelligence (AI) to analyze and gain insights about Empower patient data, physician treatment recommendations and overall long-term efficacy of patient care. The pilot program is expected to utilize Empower patient data in a HIPAA compliant manner, to determine if normalized data can be generated using Datametrex AI solutions to understand how patient care and efficacy of physician-guided treatment recommendations are positively impacting serious qualifying conditions of patients.

  • Empower Clinics Announces Major Acquisition
    CNW Group4 months ago

    Empower Clinics Announces Major Acquisition

    VANCOUVER, Jan. 28, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company") today announces it has entered into a non-binding term sheet to acquire the business of Sun Valley Certification Clinics Holdings LLC ("Sun Valley"), including its interests in certain affiliates thereof, by way of a share or asset acquisition, subject to due diligence and customary closing conditions. Sun Valley operates a network of professional medical cannabis and pain management practices, with five clinics in Arizona, one clinic in Las Vegas, a tele-medicine platform serving California, and a fully developed franchise business model for the domestic cannabis industry, which is believed to be the first of its kind in the United States. The proposed transaction is expected to create one of the largest clinic groups in the medical cannabis sector in the United States, with twelve physical locations having a combined patient count of 165,000 patients in Washington, Oregon, Illinois, Arizona, Nevada and California, and the potential to rapidly expand the clinic network via the Sun Valley franchise program.

  • Empower Clinics Provides Corporate Update
    CNW Group4 months ago

    Empower Clinics Provides Corporate Update

    SEATTLE, WA, Jan. 17, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE:EPW.CN - News) (Frankfurt 8EC) ("Empower" or the "Company") today provided a corporate update on operations and changes to its board of directors. The Company is pleased to announce its first production run of Sollievo CBD lotion has commenced selling in two test markets - Portland, OR and Seattle, WA.

  • Business Wire6 months ago

    Empower Clinics to Launch Telemedicine Platform for Medical Cannabis, Wellness Treatment

    Empower Clinics Inc. (https://www.empowerclinics.com), (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it is nearing completion of a telemedicine platform that will enable interested patients worldwide to connect with its specialized medical doctors. Expected to launch in December via Empower’s Website, the telemedicine offering will make it easy for patients worldwide to speak directly with medical doctors about anything related to cannabis-based treatments as well as overall wellness. “Telemedicine leverages two of Empower’s greatest assets, in bringing together technology with Empower’s highly specialized medical doctors to provide patients with the expertise they need where and when they want it,” said Craig Snyder, Empower CEO.

  • GlobeNewswire6 months ago

    Integrated Cannabis Company, Inc. Signs Definitive Agreement with Empower Clinics Inc. and Receives Purchase Order

    FRA: 8EC) (“Empower”), a leading owner and operator of medical cannabis and wellness clinics in the United States (US). Empower has more than 25,000 patients under care across 15 locations with medical cannabis treatments in Oregon, Washington and Illinois. “This milestone marks another significant move for distribution of X-SPRAYS™ with its first shipment to the Chicago market.

  • Business Wire7 months ago

    Empower Clinics Salutes Military Veterans with 50% Discounts at Chicago Medical Cannabis and Wellness Clinic

    Empower Clinics Inc. (https://www.empowerclinics.com) (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that its recently opened clinic in downtown Chicago will honor all US military veterans by offering 50% discounts on its services through the end of 2018. One of Empower Clinics’ main focuses is helping military veterans obtain medical cannabis registry cards for treatment of Post-Traumatic Stress Disorder (PTSD) and its side effects associated with pain, sleep and stress. Empower’s medical doctors and staff can guide veterans through the state of Illinois’ 40 qualifying conditions, physician certification and registry card application forms required by the Illinois Department of Public Health.

  • Business Wire7 months ago

    Empower Clinics and Inolife R&D Announce Letter of Intent for US Distribution Agreement for Needle-free Treatments

    Empower Clinics Inc. (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it has signed a letter of intent for a national distribution agreement with Inolife R&D, an emerging specialty medical device company. Under the agreement, Empower Clinics will make Inolife’s pioneering needle-free injection devices available to patients at Empower’s 15 clinics in Oregon, Washington, and Illinois. Inolife developed its Inojex 30 and Nanojex devices to be easy-to-use, safe, pain-free, and more efficient in delivering treatment to patients than is possible with traditional needle-based injections.

  • Empower Clinics to Launch CBD Medical Cannabis Products under “Sollievo” Brand throughout North America
    Business Wire7 months ago

    Empower Clinics to Launch CBD Medical Cannabis Products under “Sollievo” Brand throughout North America

    Empower Clinics Inc. (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced a comprehensive agreement with Titration Technologies, LLC, an innovator in cannabis product development, to manufacture, package, and fulfill Empower’s “Sollievo” CBD medical cannabis products throughout North America. As part of the agreement, Titration will produce Empower-formulated CBD medical cannabis products, which Empower will sell under its “Sollievo” product brand on Empower’s Website, at Empower clinics, as well as select third-party wellness clinics throughout the US and Canada. “This agreement enables patients in all 50 states and Canada to access Empower’s CBD products, which is an important milestone as we continue to expand our business and service areas,” said Craig Snyder, Empower CEO.

  • Business Wire8 months ago

    Empower Clinics Announces US Distribution Agreement with Integrated Cannabis Company

    FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced a national distribution agreement with Integrated Cannabis Company, Inc. (ICAN.CN) (ICNAF). Both companies have engaged with their marketing and distribution teams to streamline the logistics of rolling out new products in the Empower clinics. The CBD products are non-psychotropic: they do not directly affect mood, perception, or consciousness.

  • Business Wire8 months ago

    Empower Clinics CEO to Address State of the Cannabis Industry Conference

    Empower Clinics Inc. (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that CEO Craig Snyder will participate in a leadership panel presentation, “How Tech & Data are Shaping the Industry,” as part of the second annual State of the Cannabis Industry Conference to be held in Boston on October 4. New York City-based Viridian Capital Advisors, a financial and strategic advisory firm dedicated to the cannabis industry, and Burns & Levinson LLP, a Boston law firm at the forefront of advising national businesses in the cannabis space, are presenting the second annual State of the Cannabis Industry Conference: Growth Opportunities for Professionals, Operators, and Investors. This invitation-only event explores opportunities in the rapidly growing, multi-billion-dollar cannabis industry and investment considerations for professional investors.

  • Business Wire8 months ago

    Empower Clinics Encouraged by US Drug Enforcement Administration’s (DEA) Decision on CBD-based Treatment

    FRA 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today issued a statement regarding the US Department of Justice and Drug Enforcement Agency’s (DEA) decision late last week to place a cannabidiol (CBD)-based treatment, Epidiolex, in schedule V of the Controlled Substances Act (CSA), the least restrictive schedule of the CSA. In June, the Food and Drug Administration (FDA) announced that it approved Epidiolex for treating two severe form of epilepsy. “We are very encouraged by this move, as we believe it will set the stage for potentially more Federally approved medications with CBD,” said Craig Snyder, Empower CEO.

  • Business Wire8 months ago

    Empower Clinics Announces Escrow Lock-Up Agreements with Company Insiders Covering More Than 40% of Outstanding Shares

    FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that officers of the company, as well as significant founding shareholders of Empower’s predecessor company, have entered a three-year escrow related to the company common shares that represent more than 40% of the company’s currently issued and outstanding shares. The escrow agreements provide that these shareholders will not sell or otherwise dispose of any shares, or enter into any transaction to such effect, directly or indirectly, unless detailed provisions of the escrow are met. The company also announced that it intends to close a non-brokered private placement (the “Offering”) of an aggregate principal amount of $575,060 in convertible debentures (the “Convertible Debentures”).